- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00580632
Study Evaluating Workload, Clinical and Therapeutic Management of Psoriatic Arthritis
May 13, 2010 updated by: Wyeth is now a wholly owned subsidiary of Pfizer
Workload, Clinical and Therapeutic Management of Psoriatic Arthritis
In Spain, there is little data available concerning the evolution and treatment of Psoriatic Arthritis by rheumatologists and dermatologists.
This study is designed to obtain more data about the clinical and therapeutic management of Psoriatic Arthritis in Dermatology and Rheumatology Medical centers.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
300
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Psoriatic Arthritis Patients with a representative geographic sample
Description
Inclusion Criteria:
- patients older than 18 years with a psoriatic arthritis diagnosis that go to dermatologic and/or rheumatologic centers or primary care centers.
- patients that receive pharmacologic treatment for their condition
- patients that give their written consent to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Determine diagnosis and evolution time of patients
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Primary Completion (Actual)
September 1, 2007
Study Completion (Actual)
September 1, 2007
Study Registration Dates
First Submitted
December 21, 2007
First Submitted That Met QC Criteria
December 26, 2007
First Posted (Estimate)
December 27, 2007
Study Record Updates
Last Update Posted (Estimate)
May 14, 2010
Last Update Submitted That Met QC Criteria
May 13, 2010
Last Verified
December 1, 2007
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0881A-102389
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psoriatic Arthritis
-
AmgenRecruitingActive Juvenile Psoriatic ArthritisSpain, France, Greece, Italy, United Kingdom, Austria, Germany, Netherlands, Lithuania, Romania, South Africa, Portugal, Belgium, Turkey (Türkiye), Poland
-
Dr. Schär AG / SPAASST Gaetano Pini-CTOCompleted
-
Bristol-Myers SquibbCompletedPsoriatic Arthritis (PsA)Germany
-
Pope Research CorporationAmgenWithdrawn
-
Universitätsklinikum Hamburg-EppendorfBristol-Myers Squibb; Eli Lilly and Company; UCB Pharma; Merck Sharp & Dohme LLC; AbbVi... and other collaboratorsRecruiting
-
Medical College of WisconsinNot yet recruitingPsoriatic Arthritis (PsA)United States
-
Sun Pharmaceutical Industries LimitedActive, not recruitingActive Psoriatic ArthritisUnited States, Australia, Czechia, Germany, India, Japan, Poland, Spain, South Korea
-
AbbVieActive, not recruitingPsoriatic Arthritis (PsA)United States, Australia, Belgium, Canada, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, New Zealand, Puerto Rico, Singapore, South Africa, Spain, Sweden, United Kingdom, Argentina, Brazil, Denmark, P... and more
-
Chao JiEnrolling by invitationSubclinical Psoriatic ArthritisChina
-
Sun Pharmaceutical Industries LimitedCompleted